News

Let us introduce you to the organization who wants to promote the professional development of psychiatrists as leaders.

Today is International Overdose Awareness Day!

Three eulogies for the Labor Day weekend.

A psychiatrist has an undeniable response to the Jacksonville shooting.

Let's think about the positives in psychiatry...

The funds will be distributed over the course of 5 years to support preclinical through phase 2 studies.

In this insightful interview, experts discuss the journey toward a more humanistic approach in psychiatry, the challenges of integrating biological and psychosocial aspects, and the need for comprehensive training for future psychiatrists.

Generics are now approved for adults in the treatment of BED and for individuals aged 6 years and older in the treatment of ADHD.

How can clinicians recognize and acknowledge the injustices often experienced by COVID long-haulers?

A recent survey found mental health and finances were some of the top stressors for college students.

Travel: a state of mind.

Patient suicide is both personally challenging and legally complicated for mental health professionals. Are you providing the standard of care? How do you balance confidentiality and family support? When is split treatment justified by reduced liability exposure? Difficult questions — but not impossible. Download this guide, provided by Professional Risk Management Services® (PRMS®), for proven risk management and patient safety approaches.

As we commemorate the landmark March on Washington, parallels are drawn between Dr Martin Luther King Jr's dreams of equality and the goals of social psychiatry, highlighting the need to address social determinants of mental health.

“The Genain quadruplets have really gone down in psychiatric history for being the ‘poster girls’ for psychiatric genetics.”

Researchers investigated the prevalence and correlates of sleep disorders in patients with first-episode psychosis.

From informed consent in treatment with psychedelics to an anti-fentanyl antibody that may reverse the signs of carfentanil overdose, here are highlights from the week in Psychiatric Times.

A psychiatrist discusses his hobby of juggling and demonstrates a few tricks.

What is new in research on major depressive disorder?

A great day, indeed.

The series explores the origins of the first opioid crisis in the United States.

How can you best get patients with a brain injury back to work?

Explore the complex interaction of cannabis and psychosis, and the sociocultural stressors and resulting neurobehavioral symptoms.

In this CME article, learn more about the best practices for engaging patients in the informed consent process for psychedelic treatment and psychedelic-assisted psychotherapy.

If you could be a psychiatrist at a different time in history, when would you practice?

Report reviews key study results and provides updates on additional studies in development.

"The root of the word 'create' or 'creativity' essentially means 'to grow.' That is probably what lies at the heart of what patients really want; they want to grow in terms of their relationships, their abilities, their passions and interests, their health, and in terms of whatever dreams they want to achieve personally in their lives."

"By developing strategies that reduce both stigma and normalization, we can create a more supportive environment for those at risk and improve suicide prevention efforts."

Awais Aftab, MD, and author Audrey Clare Farley, PhD, discuss Girls and Their Monsters: The Genain Quadruplets and the Making of Madness in America.

“We expect this antibody to be a valuable new weapon for fighting the opioid crisis.”

The body keeps the score...